Jensen Receives $1.4M to Study How MEK and Drugs that Inhibit MEK Affect Mitochondria in Heart Muscle and Breast Cancer Cells
February 22, 2024
Brian Jensen, MD, PI, received a R01, $1.4M direct, grant from the NIH’s National Heart, Lung, and Blood Institute. The researches will investigate how MEK (Mitogen-Activated Protein Kinase Kinase) and drugs that inhibit MEK affect mitochondria within two types of cells: cardiomyocytes (heart muscle cells) and triple-negative breast cancer cells....